Novavax
NVAX
#5394
Rank
โ‚น141.46 B
Marketcap
โ‚น860.27
Share price
-1.43%
Change (1 day)
30.19%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2025 (TTM): โ‚น39.18 Billion

According to Novavax's latest financial reports the company's current earnings are โ‚น1.08 Billion. , an increase over its 2024 earnings that were of -โ‚น15.09 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2025

Annual earnings

Year Earnings Change
2025 โ‚น44.76 B-396.87%
2024 -โ‚น15.09 Billion-70.39%
2023 -โ‚น50.93 Billion-16.59%
2022 -โ‚น61.06 Billion-62.58%
2021 -โ‚น163.17 Billion320.54%
2020 -โ‚น38.8 Billion234.22%
2019 -โ‚น11.61 Billion-30.17%
2018 -โ‚น16.63 Billion1.69%
2017 -โ‚น16.35 Billion-36.44%
2016 -โ‚น25.73 Billion70.4%
2015 -โ‚น15.1 Billion89.27%
2014 -โ‚น7.98 Billion59.83%
2013 -โ‚น5 Billion81.9%
2012 -โ‚น2.75 Billion50.33%
2011 -โ‚น1.83 Billion
2009 -โ‚น3.61 Billion8.8%
2008 -โ‚น3.32 Billion18.01%
2007 -โ‚น2.81 Billion18.33%
2006 -โ‚น2.38 Billion168.31%
2005 -โ‚น0.89 Billion-62.51%
2004 -โ‚น2.36 Billion52.4%
2003 -โ‚น1.55 Billion-28.21%
2002 -โ‚น2.16 Billion
2000 -โ‚น1.23 Billion177%
1999 -โ‚น0.45 Billion-11.54%
1998 -โ‚น0.51 Billion10.64%
1997 -โ‚น0.46 Billion-9.62%
1996 -โ‚น0.51 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
โ‚น1.520 T 3,296.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น1.020 T 2,179.04%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.412 T 3,055.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น964.44 B 2,054.31%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-โ‚น67.65 Billion-251.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น27.69 Billion-161.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚น1.99 B-95.55%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-โ‚น0.79 Billion-101.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚น25.75 B-42.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น15.92 B-64.43%๐Ÿ‡บ๐Ÿ‡ธ USA